Medicare Enrolled

Dr. Orlando Almanza, MD

Cardiovascular Disease · South Miami, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
6200 SUNSET DR, South Miami, FL 33143
3056664633
In practice since 2005 (20 years)
NPI: 1164412276 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Almanza from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Almanza? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Almanza

Dr. Orlando Almanza is a cardiovascular disease in South Miami, FL, with 20 years in practice. Based on federal Medicare data, Dr. Almanza performed 2,402 Medicare services across 1,228 unique beneficiaries.

Between the years covered by Open Payments, Dr. Almanza received a total of $6,794 from 37 pharmaceutical and/or device companies across 270 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Almanza is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 49% volume in FL$ $6,794 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,402
Medicare services
Top 49% in FL for cardiovascular disease
1,228
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~120 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)730$66$195
Remote patient monitoring management, 20 min/month344$37$105
Electrocardiogram (EKG), 12-lead244$11$36
Remote patient monitoring device, 30 days243$40$110
EKG interpretation and report153$7$13
Regadenoson injection (Lexiscan) for heart stress test116$41$110
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes115$31$91
Echocardiogram, transthoracic84$153$486
Technetium tc-99m tetrofosmin, diagnostic, per study dose74$351$500
New patient office visit (45-59 min)53$127$360
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician52$53$150
Nuclear medicine studies of heart muscle at rest and with stress and spect37$354$960
Office visit, established patient (30-39 min)31$88$270
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries26$313$798
Blood draw (venipuncture)25$6$6
Hospital follow-up visit, high complexity21$102$220
Initial hospital admission, high complexity17$148$430
Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan13$2,281$5,000
Nuclear medicine study of heart muscle blood flow by pet12$151$500
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional12$14$46
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.5% high complexity
9.6% medium
86.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,794
Total received (2018-2024)
Avg $971/year across 7 years
Top 32% in FL for cardiovascular disease
37
Companies
270
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,722 (98.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$72 (1.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,015
2023
$621
2022
$648
2021
$449
2020
$299
2019
$2,611
2018
$1,150

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$1,214
PFIZER INC.
$550
Amgen Inc.
$522
E.R. Squibb & Sons, L.L.C.
$509
Medtronic, Inc.
$485
Novartis Pharmaceuticals Corporation
$474
Abbott Laboratories
$357
Gilead Sciences, Inc.
$332
Medtronic Vascular, Inc.
$307
Janssen Pharmaceuticals, Inc
$216
Edwards Lifesciences Corporation
$202
Merck Sharp & Dohme Corporation
$180
Kiniksa Pharmaceuticals International, plc
$168
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$146
Insmed, Inc.
$130
HEARTFLOW, INC.
$118
AstraZeneca Pharmaceuticals LP
$103
Lexicon Pharmaceuticals, Inc.
$97
Kiniksa Pharmaceuticals, Ltd.
$86
BIOTRONIK INC.
$72
Astellas Pharma US Inc
$63
GE HEALTHCARE
$57
Esperion Therapeutics, Inc.
$54
SANOFI-AVENTIS U.S. LLC
$54
ATRICURE, INC.
$52
Amarin Pharma Inc.
$31
Philips North America LLC
$29
Merck Sharp & Dohme LLC
$24
SCPHARMACEUTICALS INC.
$22
BOSTON SCIENTIFIC CORPORATION
$20
Bayer Healthcare Pharmaceuticals Inc.
$20
Impulse Dynamics (USA) Inc.
$19
Akcea Therapeutics, Inc.
$18
Azurity Pharmaceuticals, Inc.
$18
Novo Nordisk Inc
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Allergan Inc.
$11
Top 3 companies account for 33.7% of total payments
Associated products mentioned in payments ›
(CK4) MCOT · ADVISA DR MRI SURESCAN · AZURE XT DR MRI SURESCAN · Arcalyst · Arikayce · Azure · BYSTOLIC · CAMZYOS · CHANTIX · COBALT DR MRI SURESCAN · CareLink · Claria MRI · Cobalt · Confirm Rx · Corlanor · EDARBYCLOR · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · FARXIGA · FFRct · FUROSCIX · Inpefa · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · LINQ II · LifeVest · MICRA · MITRACLIP · MULTAQ · Merlin Connectivity and Remote · Micra · Mitra Clip system · MitraClip System · NAVITOR · NEXLETOL · Optimizer · Ranexa · Repatha · Rybelsus · TEGSEDI · VENASEAL · VERQUVO · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $283 per 100 Medicare services performed
Looking for a cardiovascular disease in South Miami?
Compare cardiovascular diseases in the South Miami area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
340
Per 100K population
12.7
County median income
$68,694
Nearest hospital
SOUTH MIAMI HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Almanza is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Almanza experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Almanza performed 730 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Almanza receive payments from pharmaceutical companies?
Yes. Dr. Almanza received a total of $6,794 from 37 companies across 270 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Almanza's costs compare to other cardiovascular diseases in South Miami?
Dr. Almanza's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Almanza) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →